CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 67 enrolled
Drug / intervention
LIVE-R Life Educationbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04272619
NCT04272619N/ACompleted
CompareCT.gov

LIVE-R Life: Liver Cancer Education

Fox Chase Cancer Center·interventional·Posted Feb 17, 2020·Updated Jan 8, 2025

In Brief

A clinical study evaluating LIVE-R Life Education for Liver Cancer. Completed, enrolled 67 participants across 1 site.

Detailed Summary

This study proposes to bridge the gap between evidence and action and combat rising liver cancer rates attributed to Hepatitis B and C infection in Philadelphia by identifying neighborhoods with higher than expected rates of liver cancer and related risk factors and administering an educational intervention about liver cancer and neighborhood health in those communities, working with existing community partners at Fox Chase Cancer Center.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLiver Cancer
CountriesUnited States
CollaboratorsPennsylvania Department of Health

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedFeb 17, 2020
Enrollment StartFeb 11, 2020
Primary CompletionApr 6, 2023
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 6.4 years ago

Interventions

LIVE-R Life Educationbehavioral

A health educator will present participants with a 30-minute PowerPoint presentation containing educational information about liver cancer risk, screening, prevention, symptoms, and treatments, as well as introduce the concept of neighborhood health (e.g., rates of liver cancer and related risk factors in a census tract and how that might influence individual cancer risk).